Page last updated: 2024-11-02

benoxinate and Head and Neck Neoplasms

benoxinate has been researched along with Head and Neck Neoplasms in 1 studies

benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackwell, N1
Bax, K1
Adsett, S1

Other Studies

1 other study available for benoxinate and Head and Neck Neoplasms

ArticleYear
Topical ophthalmic anaesthesia for severe facial pain due to recurrent head and neck carcinoma.
    Palliative medicine, 1995, Volume: 9, Issue:3

    Topics: Anesthetics, Local; Cornea; Facial Pain; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplas

1995